Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles
MARIA AYALA VALVERDE; Jorge Arnold Alvarez; Gustavo Ayares; Francisco Barrera; Daniel Cabrera; Luis Antonio Diaz; Juan Pablo Arab; Ibon Martinez-Arranz; Cristina Alonso; Jesús M. Bañales; Marco Arrese;
Ann Hepatol. 2024;29 Supl 3:
P- 53 NATURAL KILLER CELLS OF EARLY STAGES OF METABOLIC FATTY LIVER DISEASE PRESENT REDUCED CYTOTOXICITY AGAINST TUMOR CELLS. CASE- CONTROL ANALYSIS
Nixa Paola Olivares; Daniel Ernst; Maria Cecilia Poli; Gustavo Pinto; Francisca Allendes; Vanessa Oyarzún; Nancy Solis; Marco Arrese; Juan Pablo Arab; Daniel Cabrera; Luis Antonio Diaz; Francisco Barrera;
Ann Hepatol. 2024;29 Supl 1:
O-20 EFFECTS OF ISOCALORIC AND NEGATIVE CALORIE BALANCE EXERCISE ON SERUM LEVELS OF INSULIN-LIKE GROWTH FACTOR TYPE 1 IN SUBJECTS WITH INITIAL AND ADVANCED FATTY LIVER
María Jesús Fuenzalida; Francisco Barrera; Hermann Mies; Valeria Correa; Francisca Allendes; Nancy Solis; Vanessa Oyarzún; Luis Antonio Díaz; Marco Arrese; Juan Pablo Arab; Daniel Cabrera; Felipe Contreras; Santiago Riquelme; Catterina Ferreccio; Laura Andrea Huidobro; María De Los Ángeles Spencer; Macarena Garrido; Jennifer Loyola; Paola Correa; Felipe Sobarzo; Paula Silva; Cristian Herrera; Franco Godoy;
Ann Hepatol. 2024;29 Supl 1: